Wexford Capital »

Janux Therapeutics shares owned by Wexford Capital

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Wexford Capital from 13F filings

Historical chart of Wexford Capital investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Wexford Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Wexford Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $35k 1.4k 24.44
2025-06-30 $151k 6.5k 23.10

More positions owned by Wexford Capital

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Mammoth Energy Svcs (TUSK)
Nephros (NEPH)
Core Natural Resources Com Shs (CNR)
EQT Corporation (EQT)
Chesapeake Energy Corp (EXE)
Energy Transfer Com Ut Ltd Ptn (ET)
Teekay Tankers Cl A (TNK)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Imperial Pete Com New (IMPP)
Acm Resh Com Cl A (ACMR)
Enterprise Products Partners (EPD)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Century Aluminum Company (CENX)
Antero Res (AR)

View all positions for Wexford Capital

Top funds holding Janux Therapeutics

RA Capital Management
FMR
Henderson Group
BlackRock
Paradigm Biocapital Advisors
Adage Capital Partners GP
Vanguard Group
State Street Corporation
OrbiMed Advisors
Point72 Asset Management
Logos Global Management
Geode Capital Management
Woodline Partners
T. Rowe Price Investment Management
Readystate Asset Management

View all funds holding Janux Therapeutics